CUFinder

Guray Saydam

About Guray Saydam

Guray Saydam, With an exceptional h-index of 20 and a recent h-index of 11 (since 2020), a distinguished researcher at Ege Üniversitesi, specializes in the field of Hematoloji.

His recent articles reflect a diverse array of research interests and contributions to the field:

Nilotinib exerts a therapeutic approach via JAK/STAT pathway and cytokine network in chronic myeloid leukemia cells

Non-Hodgkin's Lymphoma of The Tonsil: Clinical Features, Treatment Response and Prognosis

Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience

İmmün-Tedavilerle İlişkili Toksisite Yönetimi

Mantle Hücreli Lenfomanın Agresif Varyantları (Blastoid/Pleomorfik), Klinik Özellikler ve Güncel Tedavi

Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye

Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores

Keynote-B68: Updated Efficacy and Safety of Pembrolizumab Every Six Weeks in Relapsed/Refractory Classical Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma

Guray Saydam Information

University

Position

Tıp Fakültesi Hematoloji Bilim Dalı Profesör

Citations(all)

1144

Citations(since 2020)

473

Cited By

1040

hIndex(all)

20

hIndex(since 2020)

11

i10Index(all)

32

i10Index(since 2020)

13

Email

University Profile Page

Google Scholar

Guray Saydam Skills & Research Interests

Hematoloji

Top articles of Guray Saydam

Nilotinib exerts a therapeutic approach via JAK/STAT pathway and cytokine network in chronic myeloid leukemia cells

Ege Tıp Dergisi

2024/3/19

Nur Soyer
Nur Soyer

H-Index: 6

Non-Hodgkin's Lymphoma of The Tonsil: Clinical Features, Treatment Response and Prognosis

Ege Tıp Dergisi

2024/3/19

Nur Soyer
Nur Soyer

H-Index: 6

Mine Hekimgil
Mine Hekimgil

H-Index: 9

Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience

Leukemia Research

2024/5/1

Fatma Keklik Karadağ
Fatma Keklik Karadağ

H-Index: 3

Tuğrul Elverdi
Tuğrul Elverdi

H-Index: 8

Muhlis Cem Ar
Muhlis Cem Ar

H-Index: 11

İmmün-Tedavilerle İlişkili Toksisite Yönetimi

Turkiye Klinikleri Hematology-Special Topics

2023

Mantle Hücreli Lenfomanın Agresif Varyantları (Blastoid/Pleomorfik), Klinik Özellikler ve Güncel Tedavi

Turkiye Klinikleri Medical Pathology-Special Topics

2023

Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye

Turkish Journal of Hematology

2023/12

Müzeyyen Aslaner Ak
Müzeyyen Aslaner Ak

H-Index: 0

Fatma Keklik Karadağ
Fatma Keklik Karadağ

H-Index: 3

Sinan Demircioğlu
Sinan Demircioğlu

H-Index: 5

Mustafa Merter
Mustafa Merter

H-Index: 4

Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores

Turkish Journal of Hematology

2023/12

Fatma Keklik Karadağ
Fatma Keklik Karadağ

H-Index: 3

Burhan Turgut
Burhan Turgut

H-Index: 1

Sinan Demircioğlu
Sinan Demircioğlu

H-Index: 5

Keynote-B68: Updated Efficacy and Safety of Pembrolizumab Every Six Weeks in Relapsed/Refractory Classical Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma

Blood

2023/11/28

Estelle Verburgh
Estelle Verburgh

H-Index: 7

Antonio Pinto
Antonio Pinto

H-Index: 33

Turk J Hematol Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Turkey Tekinalp A. et al: Daratumumab in RRMM

2023/11/13

Fatma Keklik Karadağ
Fatma Keklik Karadağ

H-Index: 3

Sinan Demircioğlu
Sinan Demircioğlu

H-Index: 5

Turk J Hematol Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients; the Role for PLASMIC and French Scores Baysal et al. Immune Thrombotic Thrombocytopenic Purpura …

2023/10/4

Fatma Keklik Karadağ
Fatma Keklik Karadağ

H-Index: 3

Burhan Turgut
Burhan Turgut

H-Index: 1

Sinan Demircioğlu
Sinan Demircioğlu

H-Index: 5

CT-127 Evaluation of Cytomegalovirus Infection/Disease Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation: A Single Center Experience

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

MPN-138 Hematuria in Adult Hemophilic Individuals: Is It the Only Cause of Hemophilia? A Single-Center Experience

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

CT-230 Evaluation of BK Polyomavirus Infection Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation (allo-SCT): A Single Center Experience

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

ABCL-152 Evaluation of Safety Profile of Rituximab+ Lenalidomide Protocol in Frail Elderly Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

CT-129 A Rare, Challenging Disease: Langerhans Cell Histiocytosis, a Single-Center Experience

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Nur Soyer
Nur Soyer

H-Index: 6

CT-235 A Rare Etiology of Hepatomegaly: Extramedullary Hematopoiesis After Allogeneic Stem Cell Transplantation

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Nur Soyer
Nur Soyer

H-Index: 6

CLL-147 Chronic Hepatitis B Infection Management During Long-Term Follow-Up of Chronic Lymphocytic Leukemia (CLL) Treated With Multiple Lines of Chemoimmunotherapy, Including …

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Nur Soyer
Nur Soyer

H-Index: 6

MDS-145 A Successful Treatment of Relapsed/Refractory MDS Patient who is Followed Under Hemodialysis

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Nur Soyer
Nur Soyer

H-Index: 6

CT-232 Evaluation of the Effects of Cytomegalovirus and BK Polyomavirus Infections on Overall Survival Following Allogeneic Stem Cell Transplantation: A Single Center Experience

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

MPN-149 Hemophilia and Gastrointestinal Bleeding: Beyond Hemarthrosis

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Fatih Tekin
Fatih Tekin

H-Index: 3

See List of Professors in Guray Saydam University(Ege Üniversitesi)